Health Care/Hospital
LifeSpan Vision Ventures Invests in Matter Bio
NORWALK, Conn., Oct. 24, 2023 /PRNewswire/ -- LifeSpan Vision Ventures today announced an investment in Matter Bio, a longevity holding company focused on preserving genome integrity. Central to the company's philosophy is that as we age, our genome is constantly being damaged by exogenous and en...
2023-10-24 03:40
1530
LBB Specialties Announces Principal Partnership with Viscofan
NORWALK, Conn., Oct. 23, 2023 /PRNewswire/ -- LBB Specialties (LBBS), a leader inspecialty chemicals and ingredients distribution in North America, announces a new partnership with Viscofan DE, a global leader in collagen manufacturing. LBB Specialties will be Viscofan's preferred partner inthe U...
2023-10-23 23:00
1342
XINGIMAGING and MITRO BIOTECH CO., LTD. MERGE TO DELIVER FULL-SERVICE CRO OPERATIONS TO GLOBAL RESEARCH INITIATIVES
NEW HAVEN, Conn., Oct. 23, 2023 /PRNewswire/ -- XINGIMAGING, LLC, and MITRO Biotech Co., Ltd., two recognized lead companies offering quality and excellence in drug development and imaging solutions, have merged to create one company dedicated to providing a full spectrum of CRO & CDMO research s...
2023-10-23 22:38
1424
Transcenta Unveils Updated Efficacy Data from Osemitamab (TST001) Plus CAPOX as First-Line Treatment for G/GEJ Cancer Study at ESMO 2023
Latest data reveals a 55% confirmed response rate, median duration of response (DoR) and median progression-free survival (PFS) of more than 12 months for all patients treated in the expansion cohort PRINCETON, N.J. and SUZHOU, China, Oct. 23, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Tr...
2023-10-23 21:48
3572
Skyhawk Therapeutics Receives HREC Approval for a Phase 1 Study of its SKY-0515 RNA-Targeting Small Molecule for Huntington's Disease
SKY-0515 is a small molecule RNA splicing modifier developed through the company's novel SKYSTAR® platform. SKY-0515's Phase 1 study will include healthy volunteers before targetingHuntington's patients. Huntington's disease is a fatal neurological disease with no curative therapies. WALTHAM, Ma...
2023-10-23 20:00
1014
The team from Kelun-Biotech held a meeting with representatives from MSD in Madrid, Spain
CHENGDU, China, Oct. 23, 2023 /PRNewswire/ -- On October 20, 2023, the European Society for Medical Oncology (ESMO) Conference grandly commenced inMadrid, Spain . The ESMO Conference is the most esteemed and influential oncology conference inEurope, and this annual event garners the participation ...
2023-10-23 18:16
1530
Global Healthcare Accreditation Welcomes Karin Jay as President of Global Strategy and Announces Renée-Marie Stephano's Transition to CEO
New Leadership Aims to Reinforce GHA's Position as the Foremost Authority in Medical and Well-being Travel Accreditation PALM BEACH GARDENS, Fla., Oct. 23, 2023 /PRNewswire/ -- Global Healthcare Accreditation (GHA), the esteemed authority in accreditation and certification with a specialized foc...
2023-10-23 18:00
1181
Mindray Expands Its Cardiac Biomarker Portfolio with Cutting-Edge hs-cTnI and NT-proBNP Assays, Empowering Enhanced Cardiovascular Diseases Care
SHENZHEN, China, Oct. 23, 2023 /PRNewswire/ -- Mindray (SZSE: 300760), a global leader in medical devices and solutions, introduces high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The additions have enhanced Mindray's diverse portfolio of cardiac biomarkers for cardiovascu...
2023-10-23 17:53
1508
Pepsodent launches oral hygiene awareness campaign in Malaysia
Targeting B40 communities, the initiative in partnership with MAHSA University's Faculty of Dentistry and MYDIN Prihatin will include distribution of 60,000 toothpaste kits worldwide KUALA LUMPUR, Malaysia, Oct. 23, 2023 /PRNewswire/ -- Pepsodent, a family-trusted, halal oral care brand tod...
2023-10-23 16:30
1690
Hummingbird Bioscience Announces Positive Phase I Clinical Data for HMBD-001 Monotherapy Trial at the European Society for Medical Oncology Congress 2023
* HMBD-001 is Hummingbird Bioscience's proprietary anti-HER3 antibody in Phase I/IIa trials in the UK and Phase Ib trials inAustralia, targeting multiple solid tumors * The clinical data shows that HMBD-001 is safe and well-tolerated with no dose-limiting toxicities and no severe treatment-re...
2023-10-23 14:23
1423
Longbio Pharma Presented Positive Topline Phase 1 Results for LP-003 at JSA2023
TOKYO, Oct. 23, 2023 /PRNewswire/ -- Longbio Pharma (Suzhou) Co., Ltd. (abbreviated as "Longbio Pharma"), a biotech company specializing in the development of treatments for allergy, asthma, nephrology, dermatology, ophthalmology and other autoimmune diseases, oral presented the phase I data of ...
2023-10-23 12:27
1547
EBR Systems nominated for MTAA Excellence in Medical Technology award
SUNNYVALE, Calif., Oct. 23, 2023 /PRNewswire/ -- EBR Systems, Inc. (ASX:EBR),
the developer of the world's only wireless cardiac pacing device for heart
failure, is pleased to announce it has been named as a nominee for the 2023
Medical Technology Association ofAustralia
2023-10-23 12:26
1443
Cancer Prevention Scholars and Climate Crisis Experts from Korea, US and Japan Come Together, iCOOP KOREA Holds the '2023 International Symposium'
SEOUL, South Korea, Oct. 23, 2023 /PRNewswire/ -- iCOOP KOREA held the
2023-10-23 07:00
1945
CPIC Life (H.K.) Assigned by Moody's An A3 IFSR, Outlook Stable
HONG KONG, Oct. 22, 2023 /PRNewswire/ -- China Pacific Life Insurance (H.K.)
Company Limited ("CPIC Life (HK)" or "the Company") is pleased to announce that
the Company was assigned byMoody's Investors Service
2023-10-22 11:09
1996
Gene Technology Light Up the Future - Opening of the International Conference of Genomics on Eye 2023
SHENYANG, China, Oct. 21, 2023 /PRNewswire/ -- The International Conference of Genomics on Eye 2023 (the "6th ICG Eye") embraced its grand opening in Shenyang on 14th-15th October. The conference, hosted by the Shenyang Municipal People's Government, organized by the Shenyang Bureau of Science a...
2023-10-21 03:12
3327
Striving Together For A Thriving Industry, International Biopharma Industry Week Shanghai 2023 Opens
SHANGHAI, Oct. 20, 2023 /PRNewswire/ -- On October 16th, the inaugural ceremony of the 2023 International Biopharma Industry Week Shanghai (IBIWS 2023) unfolded at the Zhangjiang Science Hall inShanghai. Spanning five days, this event, themed as "Striving Together for A Thriving Industry," endeav...
2023-10-20 15:29
1789
Europlasma NV has filed a lawsuit against Nanowatt BV
FUVEAU, France, Oct. 20, 2023 /PRNewswire/ -- Europlasma NV, a wholly-owned subsidiary of Plasmalex SAS, and a global technology leader in innovative nano-coating solutions based on low pressure plasma technology,has filed a lawsuit against Nanowatt BV as well as its Director Taco 12 BV (represen...
2023-10-20 08:00
2016
Wolters Kluwer Applauded by Frost & Sullivan for Improving Healthcare Efficiencies, Quality, and Outcomes and for Its Competitive Strategies
Wolters Kluwer uniquely leverages its expertise to meet market and customer needs, positioning it to capitalize on new growth opportunities and lead in healthcare conversational AI. SAN ANTONIO, Oct. 19, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the conversational artificial inte...
2023-10-19 21:35
1560
Endeavor BioMedicines Enters License Agreement with Hummingbird Bioscience for Worldwide Rights to HMBD-501, a Next Generation HER3-Targeted Antibody-Drug Conjugate (ADC)
Endeavor obtains exclusive worldwide rights to Hummingbird Bioscience's anti-HER3 ADC to be developed for patients with HER3-expressing tumors Hummingbird Bioscience to receive upfront and milestone payments up to $430 million, plus royalties, from Endeavor BioMedicines Investigational New Drug ...
2023-10-19 20:18
1704
Qilu Pharmaceutical to Showcase Novel Anti-Cancer Drug QL1706 at ESMO Congress 2023
JINAN, China, Oct. 19, 2023 /PRNewswire/ -- Data from Qilu Pharmaceutical's clinical trial of its novel bifunctional antibody, QL1706 (iparomlimab and tuvonralimab), will be unveiled during a mini oral presentation at the European Society for Medical Oncology (ESMO) Annual Congress 2023. The ESMO...
2023-10-19 19:42
1690
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 292 media titles]
2024-04-30 10:11
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 254 media titles]
2024-05-02 01:21
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 250 media titles]
2024-04-30 15:13Most Read
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2937
